Cerebral Blood Flow Changes in Glioblastoma Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain

Bevacizumab (BEV) is increasingly used to treat recurrent glioblastoma (GBM) with some reported improvement in neurocognitive function despite potential neurotoxicities. We examined the effects of BEV on cerebral blood flow (CBF) within recurrent GBM tumor and in the contralateral middle cerebral ar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuroradiol J
Main Authors: Andre, Jalal B, Nagpal, Seema, Hippe, Daniel S, Ravanpay, Ali C, Schmiedeskamp, Heiko, Bammer, Roland, Palagallo, Gerald J, Recht, Lawrence, Zaharchuk, Greg
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2015
Assuntos:
Brain
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4757160/
https://ncbi.nlm.nih.gov/pubmed/25923677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1971400915576641
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados